862255-00-3

Basic information

• Product Name: 4H-1-Benzopyran-4-one, 7-(2-bromoethoxy)-5-hydroxy-3-(4-hydroxyphenyl)-
• CAS NO: 862255-00-3
• Molecular Formula: C17H13BrO5
• Molecular Weight: 377.191
• Mol File: 862255-00-3.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: 4H-1-Benzopyran-4-one, 7-(2-bromoethoxy)-5-hydroxy-3-(4-hydroxyphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 4H-1-Benzopyran-4-one, 7-(2-bromoethoxy)-5-hydroxy-3-(4-hydroxyphenyl)-(862255-00-3)
• EPA Substance Registry System: 4H-1-Benzopyran-4-one, 7-(2-bromoethoxy)-5-hydroxy-3-(4-hydroxyphenyl)-(862255-00-3)

Safety Data

• Hazardous Substances Data: 862255-00-3(Hazardous Substances Data)

Upstream product

• 446-72-0 5,7-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-on 
• 106-93-4 ethylene dibromide 

Downstream Products

• 1517965-03-5 genistin-ethylidene-norfloxacin 
• 1517965-18-2 genistin-ethylidene-sarafloxacin 
• 1613083-70-7 genistin-ethylidene-lomefloxacin 
• 1517965-48-8 genistin-ethylidene-ciprofloxacin 
• 1517965-63-7 genistin-ethylidene-enoxacin 
• 947603-44-3 C₂₄H₁₈N₂O₅ 
• 947603-43-2 7-(2-(1H-imidazol-1-yl)ethoxy)-5-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one 
• 947603-48-7 C₂₂H₂₄N₂O₅ 
• 947603-42-1 C₂₁H₂₂N₂O₅ 
• 947603-40-9 C₂₁H₂₁NO₆ 
• 947603-41-0 C₂₂H₂₃NO₅ 

Relevant articles and documents

Synthesis of flavonoids nitrogen mustard derivatives and study on their antitumor activity in vitro

Several novel flavonoids nitrogen mustard derivatives were synthesized and evaluated for antiproliferative activity against seven human cancer cell lines (HeLa, A549, HepG2, MCF7, SH-SY5Y, PC-3, DU145) by the MTT assay in vitro. The resulting IC50/s

Synthesis and biological evaluation of genistein-O-alkylamine derivatives as potential multifunctional anti-Alzheimer agents

A series of genistein derivatives were synthesized and evaluated as multifunctional anti-Alzheimer agents. The results showed that these derivatives had significant acetylcholinesterase (AChE) inhibitory activity; compound 5a exhibited the strongest inhib

Composition of multiple isoflavone derivatives, preparing method and medical application

The invention discloses a composition of multiple isoflavone derivatives, and further discloses a preparing method of the composition and medical application of the composition in treating diabetes. The composition of the isoflavone derivatives is prepare